Schonfeld Strategic Advisors’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-46,072
| Closed | -$1.35M | – | 2221 |
|
|
2024
Q3 | $1.35M | Sell |
46,072
-32,428
| -41% | -$954K | 0.01% | 919 |
|
|
2024
Q2 | $1.85M | Buy |
78,500
+43,000
| +121% | +$1.01M | 0.01% | 830 |
|
|
2024
Q1 | $1.35M | Buy |
+35,500
| New | +$1.35M | 0.01% | 956 |
|
|
2022
Q3 | – | Sell |
-404
| Closed | -$5K | – | 3045 |
|
|
2022
Q2 | $5K | Buy |
+404
| New | +$5K | ﹤0.01% | 2242 |
|